查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1874393

水蛭素：2025-2031年全球市佔率及排名、總收入及需求預測

Hirudin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年全球水蛭素市場規模估計為 42.23 億美元，預計到 2031 年將成長至 52.14 億美元，2025 年至 2031 年的複合年成長率為 3.1%。

本報告對希爾丁公司近期關稅調整和國際戰略反制措施進行了全面評估，評估內容包括其跨境產業佈局、資本配置模式、區域經濟相互依存關係以及供應鏈重組。

水蛭素是一種強效抗凝血​​蛋白，可提取自醫用水蛭（Hirudo medicinalis）的唾液腺。其作用機轉是直接與凝血酶結合，凝血酶是凝血過程中將纖維蛋白原轉化為纖維蛋白的酶，抑制血液凝固。這項特異性的特性使水蛭素成為一種高效的抗凝血劑，尤其適用於有血栓風險的患者。隨著生物技術的進步，水蛭素的生產已從直接從水蛭中採集轉變為利用重組DNA技術在實驗室進行大規模合成。目前，水蛭素主要用於治療血栓性疾病，例如深層靜脈栓塞症（DVT）、肺動脈栓塞和某些類型的中風。對於對肝素等傳統抗凝血劑過敏或不耐受的患者，水蛭素被認為是一種有效的替代療法。多年來，對水蛭素應用的研究催生了各種衍生物和相關藥物，如來水蛭素和地西盧定，從而擴大了其臨床應用範圍。

水蛭素的市場發展受多種因素驅動。首先，全球對血栓性疾病治療的需求不斷成長，尤其是在心血管疾病和術後患者中，這為水蛭素及其衍生物帶來了巨大的市場機會。人口老化以及血栓和血管疾病盛行率的上升，推動了對高效抗凝血劑的需求。其次，水蛭素獨特的作用機制使其在治療某些疾病方面具有優勢，尤其適用於對肝素等傳統抗凝血劑過敏的患者，這進一步擴大了水蛭素產品的市場。

然而，水蛭素市場也面臨挑戰和風險。生產成本居高不下，限制了其廣泛應用，尤其是在生物技術尚不發達的早期階段。此外，儘管水蛭素具有強烈的抗凝血作用，但在使用過程中必須密切監測患者的凝血功能，以預防出血風險。

就市場集中度而言，隨著水蛭素生產技術的成熟，市場趨於集中在少數幾家大型製藥企業手中。這些公司透過收購、研發和專利技術來維持其市場佔有率。下游需求趨勢正在多元化發展，水蛭素的應用範圍不僅包括傳統血栓性疾病的治療，還包括其他凝血障礙和術後護理。近期技術進步包括利用基因工程進行水蛭素的重組生產，這顯著提高了生產效率並降低了成本，未來有望擴大水蛭素的應用範圍。

本報告旨在對全球水蛭素市場依地區/國家、類型和應用進行全面分析，重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名。

水蛭素市場規模、估算和預測以銷售量（噸）和收入（百萬美元）為單位呈現，以2024年為基準年，並包括2020年至2031年期間的歷史數據和預測數據。我們運用定量和定性分析，幫助讀者制定業務/成長策略，評估市場競爭格局，分析自身在當前市場中的地位，並就水蛭素做出明智的商業決策。

市場區隔

公司

  • Novartis
  • Teva Pharmaceuticals
  • Pfizer, Inc
  • Pentapharm
  • DUOPUTAI
  • Abbott
  • Keyken
  • Minapharm
  • Salubris Bio
  • Hoechst AG
  • Ciba-Geigy
  • Boehringer Ingelheim
  • Sanofi
  • Xellia Pharmaceuticals
  • Haplogen Pharmaceuticals
  • Shenzhen Kangtai Biological
  • Dong-A ST

依類型分類的區隔市場

  • 天然水蛭素
  • 重組水蛭素

應用領域

  • 血栓性疾病
  • 腫瘤疾病
  • 其他

依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Hirudin was estimated to be worth US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Hirudin cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Hirudin is a potent anticoagulant protein originally derived from the salivary glands of the medicinal leech (Hirudo medicinalis). Its mechanism of action involves directly binding to thrombin, the enzyme responsible for converting fibrinogen into fibrin during the clotting process, thus preventing blood coagulation. This unique property makes hirudin a highly effective anticoagulant, especially in patients at risk of thrombus formation. With the advancement of biotechnology, the production of hirudin has shifted from being sourced directly from leeches to large-scale synthesis through recombinant DNA technology in laboratories. Currently, hirudin is primarily used in the treatment of thrombotic conditions such as deep vein thrombosis (DVT), pulmonary embolism, and certain types of strokes. It is considered an effective alternative for patients who are allergic or intolerant to traditional anticoagulants like heparin. Over the years, with increasing research into hirudin's applications, various derivatives and related drugs, such as lepirudin and desirudin, have been developed, broadening its clinical use.

The market development of hirudin is driven by several factors. Firstly, the growing global demand for the treatment of thrombotic diseases, particularly among cardiovascular patients and post-surgical individuals, presents significant opportunities for hirudin and its derivatives. With the aging population and the increasing prevalence of thrombotic and vascular diseases, there is a rising demand for effective anticoagulants. Secondly, hirudin's unique mechanism of action offers advantages in treating certain conditions, particularly for patients who are allergic to traditional anticoagulants like heparin, further driving the market for hirudin products.

However, the hirudin market faces challenges and risks. The production cost remains high, particularly in the early stages when biotechnology was not fully developed, limiting its widespread use. Additionally, although hirudin has strong anticoagulant effects, its use requires careful monitoring of the patient's coagulation function to prevent the risk of bleeding.

In terms of market concentration, as production technologies for hirudin mature, the market has become more concentrated in the hands of a few large pharmaceutical companies that maintain their market share through acquisitions, research and development, and patented technologies. The downstream demand trend is diversifying, with hirudin finding applications not only in traditional thrombotic disease treatment but also in other coagulation disorders and post-surgical care. Recent technological advances include the recombinant production of hirudin using genetic engineering, which has significantly improved production efficiency and lowered costs, potentially expanding the use of hirudin in the future.

This report aims to provide a comprehensive presentation of the global market for Hirudin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hirudin by region & country, by Type, and by Application.

The Hirudin market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hirudin.

Market Segmentation

By Company

  • Novartis
  • Teva Pharmaceuticals
  • Pfizer, Inc
  • Pentapharm
  • DUOPUTAI
  • Abbott
  • Keyken
  • Minapharm
  • Salubris Bio
  • Hoechst AG
  • Ciba-Geigy
  • Boehringer Ingelheim
  • Sanofi
  • Xellia Pharmaceuticals
  • Haplogen Pharmaceuticals
  • Shenzhen Kangtai Biological
  • Dong-A ST

Segment by Type

  • Natural Hirudin
  • Recombinant Hirudin

Segment by Application

  • Thrombosis Disease
  • Tumor Disease
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Hirudin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Hirudin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Hirudin in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Hirudin Product Introduction
  • 1.2 Global Hirudin Market Size Forecast
    • 1.2.1 Global Hirudin Sales Value (2020-2031)
    • 1.2.2 Global Hirudin Sales Volume (2020-2031)
    • 1.2.3 Global Hirudin Sales Price (2020-2031)
  • 1.3 Hirudin Market Trends & Drivers
    • 1.3.1 Hirudin Industry Trends
    • 1.3.2 Hirudin Market Drivers & Opportunity
    • 1.3.3 Hirudin Market Challenges
    • 1.3.4 Hirudin Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Hirudin Players Revenue Ranking (2024)
  • 2.2 Global Hirudin Revenue by Company (2020-2025)
  • 2.3 Global Hirudin Players Sales Volume Ranking (2024)
  • 2.4 Global Hirudin Sales Volume by Company Players (2020-2025)
  • 2.5 Global Hirudin Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Hirudin Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Hirudin Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Hirudin
  • 2.9 Hirudin Market Competitive Analysis
    • 2.9.1 Hirudin Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Hirudin Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hirudin as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Natural Hirudin
    • 3.1.2 Recombinant Hirudin
  • 3.2 Global Hirudin Sales Value by Type
    • 3.2.1 Global Hirudin Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Hirudin Sales Value, by Type (2020-2031)
    • 3.2.3 Global Hirudin Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Hirudin Sales Volume by Type
    • 3.3.1 Global Hirudin Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Hirudin Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Hirudin Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Hirudin Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Thrombosis Disease
    • 4.1.2 Tumor Disease
    • 4.1.3 Others
  • 4.2 Global Hirudin Sales Value by Application
    • 4.2.1 Global Hirudin Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Hirudin Sales Value, by Application (2020-2031)
    • 4.2.3 Global Hirudin Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Hirudin Sales Volume by Application
    • 4.3.1 Global Hirudin Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Hirudin Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Hirudin Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Hirudin Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Hirudin Sales Value by Region
    • 5.1.1 Global Hirudin Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Hirudin Sales Value by Region (2020-2025)
    • 5.1.3 Global Hirudin Sales Value by Region (2026-2031)
    • 5.1.4 Global Hirudin Sales Value by Region (%), (2020-2031)
  • 5.2 Global Hirudin Sales Volume by Region
    • 5.2.1 Global Hirudin Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Hirudin Sales Volume by Region (2020-2025)
    • 5.2.3 Global Hirudin Sales Volume by Region (2026-2031)
    • 5.2.4 Global Hirudin Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Hirudin Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Hirudin Sales Value, 2020-2031
    • 5.4.2 North America Hirudin Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Hirudin Sales Value, 2020-2031
    • 5.5.2 Europe Hirudin Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Hirudin Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Hirudin Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Hirudin Sales Value, 2020-2031
    • 5.7.2 South America Hirudin Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Hirudin Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Hirudin Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Hirudin Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Hirudin Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Hirudin Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Hirudin Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Hirudin Sales Value, 2020-2031
    • 6.3.2 United States Hirudin Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Hirudin Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Hirudin Sales Value, 2020-2031
    • 6.4.2 Europe Hirudin Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Hirudin Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Hirudin Sales Value, 2020-2031
    • 6.5.2 China Hirudin Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Hirudin Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Hirudin Sales Value, 2020-2031
    • 6.6.2 Japan Hirudin Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Hirudin Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Hirudin Sales Value, 2020-2031
    • 6.7.2 South Korea Hirudin Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Hirudin Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Hirudin Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Hirudin Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Hirudin Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Hirudin Sales Value, 2020-2031
    • 6.9.2 India Hirudin Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Hirudin Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Novartis
    • 7.1.1 Novartis Company Information
    • 7.1.2 Novartis Introduction and Business Overview
    • 7.1.3 Novartis Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Novartis Hirudin Product Offerings
    • 7.1.5 Novartis Recent Development
  • 7.2 Teva Pharmaceuticals
    • 7.2.1 Teva Pharmaceuticals Company Information
    • 7.2.2 Teva Pharmaceuticals Introduction and Business Overview
    • 7.2.3 Teva Pharmaceuticals Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Teva Pharmaceuticals Hirudin Product Offerings
    • 7.2.5 Teva Pharmaceuticals Recent Development
  • 7.3 Pfizer, Inc
    • 7.3.1 Pfizer, Inc Company Information
    • 7.3.2 Pfizer, Inc Introduction and Business Overview
    • 7.3.3 Pfizer, Inc Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Pfizer, Inc Hirudin Product Offerings
    • 7.3.5 Pfizer, Inc Recent Development
  • 7.4 Pentapharm
    • 7.4.1 Pentapharm Company Information
    • 7.4.2 Pentapharm Introduction and Business Overview
    • 7.4.3 Pentapharm Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Pentapharm Hirudin Product Offerings
    • 7.4.5 Pentapharm Recent Development
  • 7.5 DUOPUTAI
    • 7.5.1 DUOPUTAI Company Information
    • 7.5.2 DUOPUTAI Introduction and Business Overview
    • 7.5.3 DUOPUTAI Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 DUOPUTAI Hirudin Product Offerings
    • 7.5.5 DUOPUTAI Recent Development
  • 7.6 Abbott
    • 7.6.1 Abbott Company Information
    • 7.6.2 Abbott Introduction and Business Overview
    • 7.6.3 Abbott Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Abbott Hirudin Product Offerings
    • 7.6.5 Abbott Recent Development
  • 7.7 Keyken
    • 7.7.1 Keyken Company Information
    • 7.7.2 Keyken Introduction and Business Overview
    • 7.7.3 Keyken Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Keyken Hirudin Product Offerings
    • 7.7.5 Keyken Recent Development
  • 7.8 Minapharm
    • 7.8.1 Minapharm Company Information
    • 7.8.2 Minapharm Introduction and Business Overview
    • 7.8.3 Minapharm Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Minapharm Hirudin Product Offerings
    • 7.8.5 Minapharm Recent Development
  • 7.9 Salubris Bio
    • 7.9.1 Salubris Bio Company Information
    • 7.9.2 Salubris Bio Introduction and Business Overview
    • 7.9.3 Salubris Bio Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Salubris Bio Hirudin Product Offerings
    • 7.9.5 Salubris Bio Recent Development
  • 7.10 Hoechst AG
    • 7.10.1 Hoechst AG Company Information
    • 7.10.2 Hoechst AG Introduction and Business Overview
    • 7.10.3 Hoechst AG Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 Hoechst AG Hirudin Product Offerings
    • 7.10.5 Hoechst AG Recent Development
  • 7.11 Ciba-Geigy
    • 7.11.1 Ciba-Geigy Company Information
    • 7.11.2 Ciba-Geigy Introduction and Business Overview
    • 7.11.3 Ciba-Geigy Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 Ciba-Geigy Hirudin Product Offerings
    • 7.11.5 Ciba-Geigy Recent Development
  • 7.12 Boehringer Ingelheim
    • 7.12.1 Boehringer Ingelheim Company Information
    • 7.12.2 Boehringer Ingelheim Introduction and Business Overview
    • 7.12.3 Boehringer Ingelheim Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Boehringer Ingelheim Hirudin Product Offerings
    • 7.12.5 Boehringer Ingelheim Recent Development
  • 7.13 Sanofi
    • 7.13.1 Sanofi Company Information
    • 7.13.2 Sanofi Introduction and Business Overview
    • 7.13.3 Sanofi Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 Sanofi Hirudin Product Offerings
    • 7.13.5 Sanofi Recent Development
  • 7.14 Xellia Pharmaceuticals
    • 7.14.1 Xellia Pharmaceuticals Company Information
    • 7.14.2 Xellia Pharmaceuticals Introduction and Business Overview
    • 7.14.3 Xellia Pharmaceuticals Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.14.4 Xellia Pharmaceuticals Hirudin Product Offerings
    • 7.14.5 Xellia Pharmaceuticals Recent Development
  • 7.15 Haplogen Pharmaceuticals
    • 7.15.1 Haplogen Pharmaceuticals Company Information
    • 7.15.2 Haplogen Pharmaceuticals Introduction and Business Overview
    • 7.15.3 Haplogen Pharmaceuticals Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.15.4 Haplogen Pharmaceuticals Hirudin Product Offerings
    • 7.15.5 Haplogen Pharmaceuticals Recent Development
  • 7.16 Shenzhen Kangtai Biological
    • 7.16.1 Shenzhen Kangtai Biological Company Information
    • 7.16.2 Shenzhen Kangtai Biological Introduction and Business Overview
    • 7.16.3 Shenzhen Kangtai Biological Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.16.4 Shenzhen Kangtai Biological Hirudin Product Offerings
    • 7.16.5 Shenzhen Kangtai Biological Recent Development
  • 7.17 Dong-A ST
    • 7.17.1 Dong-A ST Company Information
    • 7.17.2 Dong-A ST Introduction and Business Overview
    • 7.17.3 Dong-A ST Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.17.4 Dong-A ST Hirudin Product Offerings
    • 7.17.5 Dong-A ST Recent Development

8 Industry Chain Analysis

  • 8.1 Hirudin Industrial Chain
  • 8.2 Hirudin Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Hirudin Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Hirudin Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Hirudin Market Trends
  • Table 2. Hirudin Market Drivers & Opportunity
  • Table 3. Hirudin Market Challenges
  • Table 4. Hirudin Market Restraints
  • Table 5. Global Hirudin Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Hirudin Revenue Market Share by Company (2020-2025)
  • Table 7. Global Hirudin Sales Volume by Company (2020-2025) & (Tons)
  • Table 8. Global Hirudin Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Hirudin Price by Company (2020-2025) & (US$/kg)
  • Table 10. Key Manufacturers Hirudin Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Hirudin Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Hirudin
  • Table 13. Global Hirudin Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hirudin as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Hirudin Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Hirudin Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Hirudin Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Hirudin Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Hirudin Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Hirudin Sales Volume by Type: 2020 VS 2024 VS 2031 (Tons)
  • Table 22. Global Hirudin Sales Volume by Type (2020-2025) & (Tons)
  • Table 23. Global Hirudin Sales Volume by Type (2026-2031) & (Tons)
  • Table 24. Global Hirudin Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Hirudin Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Hirudin Price by Type (2020-2025) & (US$/kg)
  • Table 27. Global Hirudin Price by Type (2026-2031) & (US$/kg)
  • Table 28. Global Hirudin Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Hirudin Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Hirudin Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Hirudin Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Hirudin Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Hirudin Sales Volume by Application: 2020 VS 2024 VS 2031 (Tons)
  • Table 34. Global Hirudin Sales Volume by Application (2020-2025) & (Tons)
  • Table 35. Global Hirudin Sales Volume by Application (2026-2031) & (Tons)
  • Table 36. Global Hirudin Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Hirudin Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Hirudin Price by Application (2020-2025) & (US$/kg)
  • Table 39. Global Hirudin Price by Application (2026-2031) & (US$/kg)
  • Table 40. Global Hirudin Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Hirudin Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Hirudin Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Hirudin Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Hirudin Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Hirudin Sales Volume by Region (Tons): 2020 VS 2024 VS 2031
  • Table 46. Global Hirudin Sales Volume by Region (2020-2025) & (Tons)
  • Table 47. Global Hirudin Sales Volume by Region (2026-2031) & (Tons)
  • Table 48. Global Hirudin Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Hirudin Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Hirudin Average Price by Region (2020-2025) & (US$/kg)
  • Table 51. Global Hirudin Average Price by Region (2026-2031) & (US$/kg)
  • Table 52. Key Countries/Regions Hirudin Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Hirudin Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Hirudin Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Hirudin Sales Volume, (2020-2025) & (Tons)
  • Table 56. Key Countries/Regions Hirudin Sales Volume, (2026-2031) & (Tons)
  • Table 57. Novartis Company Information
  • Table 58. Novartis Introduction and Business Overview
  • Table 59. Novartis Hirudin Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 60. Novartis Hirudin Product Offerings
  • Table 61. Novartis Recent Development
  • Table 62. Teva Pharmaceuticals Company Information
  • Table 63. Teva Pharmaceuticals Introduction and Business Overview
  • Table 64. Teva Pharmaceuticals Hirudin Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 65. Teva Pharmaceuticals Hirudin Product Offerings
  • Table 66. Teva Pharmaceuticals Recent Development
  • Table 67. Pfizer, Inc Company Information
  • Table 68. Pfizer, Inc Introduction and Business Overview
  • Table 69. Pfizer, Inc Hirudin Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 70. Pfizer, Inc Hirudin Product Offerings
  • Table 71. Pfizer, Inc Recent Development
  • Table 72. Pentapharm Company Information
  • Table 73. Pentapharm Introduction and Business Overview
  • Table 74. Pentapharm Hirudin Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 75. Pentapharm Hirudin Product Offerings
  • Table 76. Pentapharm Recent Development
  • Table 77. DUOPUTAI Company Information
  • Table 78. DUOPUTAI Introduction and Business Overview
  • Table 79. DUOPUTAI Hirudin Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 80. DUOPUTAI Hirudin Product Offerings
  • Table 81. DUOPUTAI Recent Development
  • Table 82. Abbott Company Information
  • Table 83. Abbott Introduction and Business Overview
  • Table 84. Abbott Hirudin Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 85. Abbott Hirudin Product Offerings
  • Table 86. Abbott Recent Development
  • Table 87. Keyken Company Information
  • Table 88. Keyken Introduction and Business Overview
  • Table 89. Keyken Hirudin Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 90. Keyken Hirudin Product Offerings
  • Table 91. Keyken Recent Development
  • Table 92. Minapharm Company Information
  • Table 93. Minapharm Introduction and Business Overview
  • Table 94. Minapharm Hirudin Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 95. Minapharm Hirudin Product Offerings
  • Table 96. Minapharm Recent Development
  • Table 97. Salubris Bio Company Information
  • Table 98. Salubris Bio Introduction and Business Overview
  • Table 99. Salubris Bio Hirudin Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 100. Salubris Bio Hirudin Product Offerings
  • Table 101. Salubris Bio Recent Development
  • Table 102. Hoechst AG Company Information
  • Table 103. Hoechst AG Introduction and Business Overview
  • Table 104. Hoechst AG Hirudin Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 105. Hoechst AG Hirudin Product Offerings
  • Table 106. Hoechst AG Recent Development
  • Table 107. Ciba-Geigy Company Information
  • Table 108. Ciba-Geigy Introduction and Business Overview
  • Table 109. Ciba-Geigy Hirudin Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 110. Ciba-Geigy Hirudin Product Offerings
  • Table 111. Ciba-Geigy Recent Development
  • Table 112. Boehringer Ingelheim Company Information
  • Table 113. Boehringer Ingelheim Introduction and Business Overview
  • Table 114. Boehringer Ingelheim Hirudin Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 115. Boehringer Ingelheim Hirudin Product Offerings
  • Table 116. Boehringer Ingelheim Recent Development
  • Table 117. Sanofi Company Information
  • Table 118. Sanofi Introduction and Business Overview
  • Table 119. Sanofi Hirudin Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 120. Sanofi Hirudin Product Offerings
  • Table 121. Sanofi Recent Development
  • Table 122. Xellia Pharmaceuticals Company Information
  • Table 123. Xellia Pharmaceuticals Introduction and Business Overview
  • Table 124. Xellia Pharmaceuticals Hirudin Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 125. Xellia Pharmaceuticals Hirudin Product Offerings
  • Table 126. Xellia Pharmaceuticals Recent Development
  • Table 127. Haplogen Pharmaceuticals Company Information
  • Table 128. Haplogen Pharmaceuticals Introduction and Business Overview
  • Table 129. Haplogen Pharmaceuticals Hirudin Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 130. Haplogen Pharmaceuticals Hirudin Product Offerings
  • Table 131. Haplogen Pharmaceuticals Recent Development
  • Table 132. Shenzhen Kangtai Biological Company Information
  • Table 133. Shenzhen Kangtai Biological Introduction and Business Overview
  • Table 134. Shenzhen Kangtai Biological Hirudin Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 135. Shenzhen Kangtai Biological Hirudin Product Offerings
  • Table 136. Shenzhen Kangtai Biological Recent Development
  • Table 137. Dong-A ST Company Information
  • Table 138. Dong-A ST Introduction and Business Overview
  • Table 139. Dong-A ST Hirudin Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 140. Dong-A ST Hirudin Product Offerings
  • Table 141. Dong-A ST Recent Development
  • Table 142. Key Raw Materials Lists
  • Table 143. Raw Materials Key Suppliers Lists
  • Table 144. Hirudin Downstream Customers
  • Table 145. Hirudin Distributors List
  • Table 146. Research Programs/Design for This Report
  • Table 147. Key Data Information from Secondary Sources
  • Table 148. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Hirudin Product Picture
  • Figure 2. Global Hirudin Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Hirudin Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Hirudin Sales Volume (2020-2031) & (Tons)
  • Figure 5. Global Hirudin Sales Price (2020-2031) & (US$/kg)
  • Figure 6. Hirudin Report Years Considered
  • Figure 7. Global Hirudin Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Hirudin Players Sales Volume Ranking (2024) & (Tons)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Hirudin Revenue in 2024
  • Figure 10. Hirudin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Natural Hirudin Picture
  • Figure 12. Recombinant Hirudin Picture
  • Figure 13. Global Hirudin Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Hirudin Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Hirudin Sales Volume by Type (2020 VS 2024 VS 2031) & (Tons)
  • Figure 16. Global Hirudin Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Hirudin Price by Type (2020-2031) & (US$/kg)
  • Figure 18. Product Picture of Thrombosis Disease
  • Figure 19. Product Picture of Tumor Disease
  • Figure 20. Product Picture of Others
  • Figure 21. Global Hirudin Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Hirudin Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global Hirudin Sales Volume by Application (2020 VS 2024 VS 2031) & (Tons)
  • Figure 24. Global Hirudin Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global Hirudin Price by Application (2020-2031) & (US$/kg)
  • Figure 26. North America Hirudin Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Hirudin Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Hirudin Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Hirudin Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Hirudin Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Hirudin Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Hirudin Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Hirudin Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Hirudin Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Hirudin Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Hirudin Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Hirudin Sales Volume (%), (2020-2031)
  • Figure 38. United States Hirudin Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Hirudin Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Hirudin Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Hirudin Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Hirudin Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Hirudin Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Hirudin Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Hirudin Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Hirudin Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Hirudin Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Hirudin Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Hirudin Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Hirudin Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Hirudin Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Hirudin Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Hirudin Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Hirudin Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Hirudin Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Hirudin Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Hirudin Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Hirudin Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Hirudin Industrial Chain
  • Figure 60. Hirudin Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed